Amblyopia Treatment for Children Aged 8 to 12 Years
ConditionAmblyopia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-12
SponsorRetina Foundation of the Southwest
About this trial
This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.
Eligibility criteria
Qualifiers
Female and male children with amblyopia age 8-12 years inclusive
Amblyopic eye visual acuity ≤ 1.0 logMar (20/32-20/200)
Interocular difference in visual acuity of 0.3 logMAR or more
Anisometropia or strabismus corrected to <5 pd
Disqualifiers
Prematurity >8 weeks
Coexisting ocular or systemic disease
Developmental delay
History of light-induced epilepsy
Trial design
Treatments tested in this trial
- Curesight dichoptic videos
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov